IART

12.25

4.97% -0.64

Dopo l'orario di chiusura: 12.39 0.14 +1.14%

Integra Lifesciences Holdings Corp (IART)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$12.89

Aprire:

$12.89

Volume 24 ore:

1.54M

Relative Volume:

1.77

Capitalizzazione di mercato:

$1.31B

Reddito:

$1.53B

Utile/perdita netta:

$40.23M

Rapporto P/E:

24.50

EPS:

0.5

Flusso di cassa netto:

$60.93M

1 W Prestazione:

-27.30%

1M Prestazione:

-36.16%

6M Prestazione:

-50.56%

1 anno Prestazione:

-51.58%

Intervallo 1D:

$12.12

$12.89

Intervallo di 1 settimana:

$11.60

$14.79

Portata 52W:

$11.60

$32.66

Integra Lifesciences Holdings Corp Stock (IART) Company Profile

Nome

Integra Lifesciences Holdings Corp

Settore

Healthcare (1174)

Industria

Medical Devices (157)

Telefono

(609) 275-0500

Indirizzo

1100 CAMPUS ROAD, PRINCETON, NJ

Dipendente

4,396

Cinguettio

@integra_life

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

IART's Discussions on Twitter

Confronta IART con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IART Integra Lifesciences Holdings Corp	12.25	1.31B	1.53B	40.23M	60.93M	0.50
ABT Abbott Laboratories	133.24	231.09B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	102.86	155.24B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	380.92	144.54B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	83.48	108.82B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	73.68	44.31B	5.54B	4.18B	623.10M	7.00

Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-31	Aggiornamento	Argus	Hold → Buy
2024-12-02	Iniziato	Morgan Stanley	Underweight
2024-10-07	Aggiornamento	BTIG Research	Sell → Neutral
2024-07-30	Downgrade	BTIG Research	Neutral → Sell
2024-07-30	Downgrade	Citigroup	Neutral → Sell
2024-05-07	Downgrade	Oppenheimer	Outperform → Perform
2024-05-07	Downgrade	Wells Fargo	Overweight → Equal Weight
2024-04-03	Aggiornamento	Citigroup	Sell → Neutral
2023-12-05	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-11-14	Iniziato	CL King	Buy
2023-08-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2023-07-12	Aggiornamento	Jefferies	Hold → Buy
2023-06-08	Downgrade	Argus	Buy → Hold
2023-05-24	Downgrade	JP Morgan	Neutral → Underweight
2023-05-23	Downgrade	Citigroup	Neutral → Sell
2022-10-12	Iniziato	Jefferies	Hold
2022-07-25	Iniziato	Morgan Stanley	Equal-Weight
2022-04-13	Downgrade	Truist	Buy → Hold
2021-12-17	Aggiornamento	JP Morgan	Underweight → Neutral
2021-09-15	Downgrade	BTIG Research	Buy → Neutral
2020-10-08	Downgrade	JP Morgan	Neutral → Underweight
2020-05-27	Iniziato	Citigroup	Neutral
2020-04-03	Iniziato	SunTrust	Buy
2020-01-07	Downgrade	Piper Jaffray	Overweight → Neutral
2020-01-07	Downgrade	Piper Sandler	Overweight → Neutral
2019-01-03	Iniziato	SunTrust	Buy
2018-11-28	Iniziato	UBS	Neutral
2018-08-07	Downgrade	BofA/Merrill	Neutral → Underperform
2018-07-26	Aggiornamento	BTIG Research	Neutral → Buy
2018-07-02	Downgrade	Citigroup	Buy → Neutral
2018-01-05	Ripresa	Cantor Fitzgerald	Neutral
2018-01-02	Downgrade	BofA/Merrill	Buy → Neutral
2017-11-09	Reiterato	RBC Capital Mkts	Sector Perform
2017-10-30	Downgrade	Wells Fargo	Outperform → Market Perform
2017-10-27	Downgrade	JP Morgan	Overweight → Neutral
2017-06-30	Iniziato	Cantor Fitzgerald	Overweight
2017-05-02	Reiterato	RBC Capital Mkts	Sector Perform
2017-01-13	Reiterato	RBC Capital Mkts	Sector Perform
2017-01-06	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2016-12-12	Iniziato	UBS	Buy

Mostra tutto

Integra Lifesciences Holdings Corp Borsa (IART) Ultime notizie

11:33 AM

Integra Lifesciences (IART): Analyst Lowers Price Target to $25 | IART Stock News - GuruFocus

11:33 AM

10:47 AM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - GlobeNewswire Inc.

10:47 AM

08:19 AM

Integra LifeSciences stock target cut to $25 by JMP - Investing.com

08:19 AM

07:02 AM

Integra LifeSciences (IART) Sees Lowered Price Target Amid Market Reaction | IART Stock News - GuruFocus

07:02 AM

May 08, 2025

JPMorgan Chase & Co. Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World

May 08, 2025

Wells Fargo & Company Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World

May 08, 2025

May 07, 2025

U.S. Regenerative Artificial Skin Market 2025-2032: Top Trends - openPR.com

May 07, 2025

May 06, 2025

Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings - Defense World

May 06, 2025

Integra LifeSciences (IART) Faces Adjusted Price Target Amid Rev - GuruFocus

May 06, 2025

Integra LifeSciences (IART) Faces Adjusted Price Target Amid Revenue Concerns | IART Stock News - GuruFocus

May 06, 2025

Wells Fargo Lowers Price Target for Integra Lifesciences (IART) - GuruFocus

May 06, 2025

JP Morgan Adjusts Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus

May 06, 2025

Wells Fargo Lowers Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus

May 06, 2025

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2025 Earnings Call Transcript - Insider Monkey

May 06, 2025

Attention Long-Term Shareholders of Integra LifeSciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office is Inv - GlobeNewswire

May 06, 2025

Wells Fargo Adjusts Integra LifeSciences (IART) Price Target | I - GuruFocus

May 06, 2025

Raymond James Financial Inc. Makes New Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World

May 06, 2025